Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries

Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in Europe. Reported treatment success rates are around 50% or less, and cure rates are even lower. To document the management and treatment outcome in patients with MDR-TB in Europe. We performed a prospective cohort study,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	American journal of respiratory and critical care medicine Ročník 198; číslo 3; s. 379 - 386
Hlavní autoři:	Günther, Gunar, van Leth, Frank, Alexandru, Sofia, Altet, Neus, Avsar, Korkut, Bang, Didi, Barbuta, Raisa, Bothamley, Graham, Ciobanu, Ana, Crudu, Valeriu, Danilovits, Manfred, Dedicoat, Martin, Duarte, Raquel, Gualano, Gina, Kunst, Heinke, de Lange, Wiel, Leimane, Vaira, McLaughlin, Anne-Marie, Magis-Escurra, Cecile, Muylle, Inge, Polcová, Veronika, Popa, Cristina, Rumetshofer, Rudolf, Skrahina, Alena, Solodovnikova, Varvara, Spinu, Victor, Tiberi, Simon, Viiklepp, Piret, Lange, Christoph
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States American Thoracic Society 01.08.2018
Témata:	Antitubercular Agents - therapeutic use Clinical outcomes Cohort Studies Drug resistance Europe - epidemiology Humans Incidence Laboratories Multidrug resistant organisms Patients Prospective Studies Treatment Outcome Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Europe Switzerland extensively drug-resistant TB TBNET outcome definitions MDR-TB management
ISSN:	1073-449X, 1535-4970, 1535-4970
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!